| 摘要 |
<p>Opiate withdrawal syndrome is treated by administration of a D2 receptor agonist, preferably a selective D2 receptor agonist. Representative compounds include apomorphine, N-allylnoraporphine, pergolide, quinpirole, propylnorapomorphine, bromocryptine, trihydroxyaporphine, methylenedioxy-propylnoraporphine, terguride and hydroxyphenyl-N-propylpiperidine.</p> |
